Accelerated Brain Volume Loss in People With Multiple Sclerosis
NCT ID: NCT05408767
Last Updated: 2022-06-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2021-01-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thalamic Nuclei Volumes in Multiple Sclerosis
NCT05002764
Early Cognitive Impairment in Multiple Sclerosis
NCT01157728
Top-Down Attentional Control of Visual-Processing
NCT01087281
Allocentric Memory in MS and Resting State Functional MRI
NCT02118298
Study of Brain Changes Shaped by Experience
NCT00006424
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National MS Center Melsbroek
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie D'hooghe
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miguel D'haeseleer
Role: PRINCIPAL_INVESTIGATOR
National MS center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nationaal Multiple Sclerose Centrum Melsbroek
Melsbroek, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BraVoLo in MS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.